Von Willebrand Factor

DRUG3 trials

Sponsors

National Center for Research Resources (NCRR), Fondazione Angelo Bianchi Bonomi, Tirol Kiniken GmbH

Conditions

Acquired Von Willebrand DiseaseType 3 Von Willebrand's DiseaseVon Willebrand's Disease

Phase 1

Phase I Study of Human Von Willebrand Factor for Von Willebrand's Disease

CompletedNCT00004667

National Center for Research Resources (NCRR)Von Willebrand's Disease

Start: 1993-10-31Target: 10Updated: 2005-06-24

Phase 2

Von Willebrand Factor Concentrate During ECMO Support

Tirol Kiniken GmbHAcquired Von Willebrand Disease

Start: 2018-04-16End: 2021-03-10Target: 68Updated: 2020-03-12

Unknown Phase

Type 3 Von Willebrand International Registries Inhibitor Prospective Study

CompletedNCT02460458

Fondazione Angelo Bianchi BonomiType 3 Von Willebrand's Disease

Start: 2012-11-05End: 2023-04-17Updated: 2024-12-27

Related Papers

Prospective Observation on the Use of Von Willebrand Factor (VWF) Concentrates in a Large Cohort of Type 3 Von Willebrand Disease (VWD): Interim (18-months) Analyses on 149 Cases Enrolled into the 3Winters-Ips Project

Blood2018-11-29